ATLANTA, Feb. 24, 2020 /PRNewswire-PRWeb/ -- OncoLens is pleased to announce it has been named one of the Top 10 Innovative Technology Companies in Georgia by the Technology Association of Georgia (TAG).
Oncology focused, OncoLens is a SaaS-based tumor board platform to help cancer centers connect members of their care teams, as they make treatment decisions for their patients. Centers can increase their referrals and streamline workflows. They can also reduce tumor board prep time by 90% and time to initiate patient treatment from 14 to 2 days.
"OncoLens utilizes some of the latest technologies in conjunction with its own proprietary algorithms to identify treatment options for the cancer patient," said Anju Mathew, Co-Founder and CEO, OncoLens. "The platform identifies clinical trials, evidence-based guidelines and personalized treatment options based on the tumor genotype. These options are proposed to the multi-disciplinary cancer care team to help them make the best decision possible for the cancer patient."
Better patient outcomes can result from OncoLens' robust functionality. Cancer care teams can engage research staff early and automatically screen cases available for clinical trials. Physicians are able to access real time data for clinical decision-making, while the system works in the background to facilitate data/document collection, including EMR clinical data, laboratory and molecular genetics test results and radiology images. The platform also supports regulatory reporting for associations such as the Commission on Cancer (CoC), NAPBC and NAPRC.
The Top 10 were selected from TAG's Top 40 Innovative Technology Companies competition for showing the highest degree of innovation, the broadest scope and financial impact of their innovations, and the greatest effect of such innovation in promoting Georgia's technology industry throughout the U.S. and globally.
As a Top 10 honoree, OncoLens will present at The Summit, hosted by TAG, March 3-4, at Cobb Galleria, in Atlanta. It is Georgia's largest technology showcase. "We look forward to sharing the future of innovative cancer care at TAG's event," said Mathew.
OncoLens develops technologies that improve cancer treatment planning, simplify tumor board management, facilitate survivorship care planning, and automate accreditations and quality reporting through an intelligent workflow engine that streamlines business processes and enables more informed clinical decision-making. For more information, visit http://www.oncolens.com.